Published in Am J Obstet Gynecol on June 01, 1991
Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev (1994) 4.94
Diagnosis of urogenital Chlamydia trachomatis infection in women based on mailed samples obtained at home: multipractice comparative study. BMJ (1996) 4.82
Qualitative analysis of psychosocial impact of diagnosis of Chlamydia trachomatis: implications for screening. BMJ (2001) 4.79
Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev (1997) 4.37
Cost effectiveness of screening for Chlamydia trachomatis: a review of published studies. Sex Transm Infect (2002) 4.14
Screening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: ecological analysis. BMJ (1998) 3.12
Chlamydial persistence: beyond the biphasic paradigm. Infect Immun (2004) 2.78
Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility. Infect Immun (1994) 2.73
Sexuality and health: the hidden costs of screening for Chlamydia trachomatis. BMJ (1999) 2.58
Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response. Infect Immun (1997) 2.43
General practice update: chlamydia infection in women. Br J Gen Pract (1995) 2.22
Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium or Chlamydia trachomatis infection. Sex Transm Infect (2005) 2.20
New point of care Chlamydia Rapid Test--bridging the gap between diagnosis and treatment: performance evaluation study. BMJ (2007) 2.08
Plaque formation by and plaque cloning of Chlamydia trachomatis biovar trachoma. J Clin Microbiol (1998) 1.98
Modelling the effectiveness of chlamydia screening in England. Sex Transm Infect (2006) 1.95
Initial route of antigen administration alters the T-cell cytokine profile produced in response to the mouse pneumonitis biovar of Chlamydia trachomatis following genital infection. Infect Immun (1996) 1.94
Characterization of Chlamydia trachomatis omp1 genotypes among sexually transmitted disease patients in Sweden. J Clin Microbiol (2001) 1.90
Comparison of performances of two commercially available tests, a PCR assay and a ligase chain reaction test, in detection of urogenital Chlamydia trachomatis infection. J Clin Microbiol (1998) 1.85
Identification of homing receptors that mediate the recruitment of CD4 T cells to the genital tract following intravaginal infection with Chlamydia trachomatis. Infect Immun (1997) 1.84
Comparison of the APTIMA CT and GC assays with the APTIMA combo 2 assay, the Abbott LCx assay, and direct fluorescent-antibody and culture assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol (2004) 1.69
Chlamydial infection in Canada. CMAJ (1992) 1.69
Characterization of ompA genotypes by sequence analysis of DNA from all detected cases of Chlamydia trachomatis infections during 1 year of contact tracing in a Swedish County. J Clin Microbiol (2004) 1.68
Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala Women's Cohort Study. Sex Transm Infect (2006) 1.59
Ability of new APTIMA CT and APTIMA GC assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in male urine and urethral swabs. J Clin Microbiol (2005) 1.43
Field-delivered therapy increases treatment for chlamydia and gonorrhea. Am J Public Health (2003) 1.41
The cost effectiveness of opportunistic chlamydia screening in England. Sex Transm Infect (2007) 1.39
Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro. Antimicrob Agents Chemother (2000) 1.35
Innate immune defences in the human endometrium. Reprod Biol Endocrinol (2003) 1.35
Characteristics of the m2000 automated sample preparation and multiplex real-time PCR system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol (2007) 1.33
Specimen processing and concentration of Chlamydia trachomatis added can influence false-negative rates in the LCx assay but not in the APTIMA Combo 2 assay when testing for inhibitors. J Clin Microbiol (2003) 1.31
High-resolution genotyping of Chlamydia trachomatis from recurrent urogenital infections. J Clin Microbiol (2000) 1.28
Chlamydia trachomatis prevalence and sexual behaviour among female adolescents in Belgium. Sex Transm Infect (1999) 1.24
Development and evaluation of an ompA quantitative real-time PCR assay for Chlamydia trachomatis serovar determination. J Clin Microbiol (2010) 1.24
Can we evaluate population screening strategies in UK general practice? A pilot randomised controlled trial comparing postal and opportunistic screening for genital chlamydial infection. J Epidemiol Community Health (2005) 1.22
Developing a realistic sexual network model of chlamydia transmission in Britain. Theor Biol Med Model (2006) 1.22
The infecting dose of Chlamydia muridarum modulates the innate immune response and ascending infection. Infect Immun (2004) 1.20
Establishment of a particle-counting method for purified elementary bodies of chlamydiae and evaluation of sensitivities of the IDEIA Chlamydia kit and DNA probe by using the purified elementary bodies. J Clin Microbiol (1992) 1.20
Characterization of Chlamydia trachomatis omp1 genotypes detected in eye swab samples from remote Australian communities. J Clin Microbiol (2004) 1.18
Time from first intercourse to first sexually transmitted infection diagnosis among adolescent women. Arch Pediatr Adolesc Med (2009) 1.17
The prevalence of Chlamydia trachomatis infection in Australia: a systematic review and meta-analysis. BMC Infect Dis (2012) 1.12
Screening of Chlamydia trachomatis genital infection in a young Parisian population. Sex Transm Infect (1999) 1.12
Transmission of Chlamydia trachomatis through sexual partnerships: a comparison between three individual-based models and empirical data. J R Soc Interface (2011) 1.12
Association of tubal factor infertility with elevated antibodies to Chlamydia trachomatis caseinolytic protease P. Am J Obstet Gynecol (2010) 1.09
PCR for detection of Chlamydia trachomatis in endocervical, urethral, rectal, and pharyngeal swab samples obtained from patients attending an STD clinic. Genitourin Med (1997) 1.08
Infectivity of Chlamydia trachomatis serovar LGV but not E is dependent on host cell heparan sulfate. Infect Immun (2001) 1.07
Recurrence of urogenital Chlamydia trachomatis infection evaluated by mailed samples obtained at home: 24 weeks' prospective follow up study. Sex Transm Infect (2000) 1.06
Persistent Chlamydiae and chronic arthritis. Arthritis Res (2001) 1.05
Incentive payments to general practitioners aimed at increasing opportunistic testing of young women for chlamydia: a pilot cluster randomised controlled trial. BMC Public Health (2010) 1.03
Pathogenesis of pelvic inflammatory disease. Genitourin Med (1993) 1.02
Infertility following pelvic inflammatory disease. Infect Dis Obstet Gynecol (1999) 1.02
Evaluation of a high resolution genotyping method for Chlamydia trachomatis using routine clinical samples. PLoS One (2011) 1.01
Best practice in primary care pathology: review 4. J Clin Pathol (2006) 1.00
Evaluation of the sensitivity and specificity of a ligase chain reaction test kit for the detection of Chlamydia trachomatis. J Clin Pathol (1996) 0.97
Differentiation of Chlamydia spp. by sequence determination and restriction endonuclease cleavage of RNase P RNA genes. J Clin Microbiol (1996) 0.97
Chlamydial infection induces host cytokinesis failure at abscission. Cell Microbiol (2012) 0.97
Chlamydia testing in community pharmacies: evaluation of a feasibility pilot in south east London. Qual Saf Health Care (2007) 0.96
Outreach health adviser in a community clinic screening programme improves management of genital chlamydia infection. Sex Transm Infect (2002) 0.95
Effectiveness of patient delivered partner medication for preventing recurrent Chlamydia trachomatis. Sex Transm Infect (1998) 0.94
Comparison of Gen-probe transcription-mediated amplification, Abbott PCR, and Roche PCR assays for detection of wild-type and mutant plasmid strains of Chlamydia trachomatis in Sweden. J Clin Microbiol (2008) 0.94
Screening for sexually transmitted diseases in rural women in Papua New Guinea: are WHO therapeutic algorithms appropriate for case detection? Bull World Health Organ (1998) 0.93
Monitoring the effectiveness of HIV and STI prevention initiatives in England, Wales, and Northern Ireland: where are we now? Sex Transm Infect (2006) 0.93
How robust are the natural history parameters used in chlamydia transmission dynamic models? A systematic review. Theor Biol Med Model (2014) 0.91
Individual and population level effects of partner notification for Chlamydia trachomatis. PLoS One (2012) 0.90
Clinical characteristics of Chlamydia trachomatis infections in a general outpatient department of obstetrics and gynaecology in the Netherlands. Sex Transm Infect (2002) 0.90
First report of performance of the Versant CT/GC DNA 1.0 assay (kPCR) for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol (2011) 0.89
Screening young adults for prevalent chlamydial infection in community settings. Ann Epidemiol (2008) 0.89
The prevalence of ureaplasma urealyticum, mycoplasma hominis, chlamydia trachomatis and neisseria gonorrhoeae infections, and the rubella status of patients undergoing an initial infertility evaluation. J Assist Reprod Genet (2008) 0.88
Sexually transmitted infections based on the syndromic approach in Gondar town, northwest Ethiopia: a retrospective study. BMC Public Health (2013) 0.88
The relationship of Chlamydia trachomatis infection and male infertility. Am J Public Health (1993) 0.87
Psychosocial impact of Chlamydia trachomatis testing in general practice. Br J Gen Pract (2006) 0.86
Molecular detection and confirmation of Neisseria gonorrhoeae in urogenital and extragenital specimens using the Abbott CT/NG RealTime assay and an in-house assay targeting the porA pseudogene. Eur J Clin Microbiol Infect Dis (2010) 0.85
Genital chlamydial infection among women in Nicaragua: validity of direct fluorescent antibody testing, prevalence, risk factors and clinical manifestations. Genitourin Med (1996) 0.85
Multinucleation during C. trachomatis infections is caused by the contribution of two effector pathways. PLoS One (2014) 0.84
Current Chlamydia trachomatis Infection, A Major Cause of Infertility. J Reprod Infertil (2012) 0.84
Prevalence and risk factors for Chlamydia trachomatis infection in adolescent females and young women in central Brazil. Eur J Clin Microbiol Infect Dis (2006) 0.82
Is urine leukocyte esterase test a useful screening method to predict Chlamydia trachomatis infection in women? J Clin Microbiol (1996) 0.82
A Stochastic Model for Assessing Chlamydia trachomatis Transmission Risk Using Longitudinal Observational Data. J R Stat Soc Ser A Stat Soc (2011) 0.82
Translation inhibition of the developmental cycle protein HctA by the small RNA IhtA is conserved across Chlamydia. PLoS One (2012) 0.82
Screening for sexually transmitted infections at home or in the clinic? Curr Opin Infect Dis (2011) 0.81
Heat shock protein expression and immunity in chlamydial infections. Infect Dis Obstet Gynecol (1999) 0.81
Significant roles played by IL-10 in Chlamydia infections. Inflammation (2014) 0.81
Prevalence of genital Chlamydia and gonococcal infections in at risk women in the kumasi metropolis, ghana. Ghana Med J (2010) 0.81
Semiparametric frailty models for clustered failure time data. Biometrics (2011) 0.80
Diagnostic evaluation of pelvic inflammatory disease. Infect Dis Obstet Gynecol (1994) 0.80
Effects of quinolone analog CI-960 in a monkey model of Chlamydia trachomatis salpingitis. Antimicrob Agents Chemother (1993) 0.79
Seropositivity of Chlamydia trachomatis among saudi pregnant women in makkah. J Family Community Med (2006) 0.78
Estimating age-dependent per-encounter chlamydia trachomatis acquisition risk via a Markov-based state-transition model. J Clin Bioinforma (2014) 0.78
Young pregnant women's views on the acceptability of screening for chlamydia as part of routine antenatal care. BMC Public Health (2010) 0.78
Use of laboratory testing for genital chlamydial infection in Norway. Qual Health Care (1993) 0.77
Reasons for testing women for genital Chlamydia trachomatis infection in the Calgary region. Can J Infect Dis (2003) 0.77
Recent acquisitions in the medical treatment of infertility caused by Chlamydia Trachomatis. J Med Life (2013) 0.77
Optimizing strategies for population-based chlamydia infection screening among young women: an age-structured system dynamics approach. BMC Public Health (2015) 0.75
Prevalence of Chlamydia trachomatis infection in parturient women in Gipuzkoa, Northern Spain. Springerplus (2016) 0.75
Safetxt: a pilot randomised controlled trial of an intervention delivered by mobile phone to increase safer sex behaviours in young people. BMJ Open (2016) 0.75
The 100 most cited articles in ectopic pregnancy: a bibliometric analysis. Springerplus (2016) 0.75
Prevalence and risk factors of chlamydia infection in Hong Kong: A population-based geospatial household survey and testing. PLoS One (2017) 0.75
Sexually transmitted diseases and infertility. Am J Obstet Gynecol (2017) 0.75
Immunopathogenesis of chlamydial pelvic inflammatory disease: the role of heat-shock proteins. Infect Dis Obstet Gynecol (1994) 0.75
Molecular Diagnosis of Sexually Transmitted Chlamydia trachomatis in the United States. ISRN Obstet Gynecol (2011) 0.75
Molecular epidemiology and genotyping of Chlamydia trachomatis infection in a cohort of young asymptomatic sexually active women (18-25 years) in Milan, Italy. J Prev Med Hyg (2016) 0.75
From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect (1999) 17.95
Elimination of syphilis in the United States. Science (1998) 2.62
Sexually transmitted diseases, pelvic inflammatory disease, and infertility: an epidemiologic update. Epidemiol Rev (1990) 2.38
Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol (1993) 1.92
Endometrial histopathology in patients with culture-proved upper genital tract infection and laparoscopically diagnosed acute salpingitis. Am J Surg Pathol (1990) 1.88
The effect of treating sexually transmitted diseases on the transmission of HIV in dually infected persons: a clinic-based estimate. Ad Hoc STD/HIV Transmission Group. Sex Transm Dis (2000) 1.72
The changing paradigm of sexually transmitted disease control in the era of managed health care. JAMA (1998) 1.67
Preventing pelvic inflammatory disease. JAMA (1991) 1.56
Screening for chlamydia--a key to the prevention of pelvic inflammatory disease. N Engl J Med (1996) 1.36
Microbial causes of proven pelvic inflammatory disease and efficacy of clindamycin and tobramycin. Ann Intern Med (1986) 1.30
Prevention agenda for genital herpes. Sex Transm Dis (1999) 0.99
Determinants of emergence of antibiotic-resistant Neisseria gonorrhoeae. J Infect Dis (1989) 0.99
Surrogate methods to diagnose gonococcal and chlamydial cervicitis: comparison of leukocyte esterase dipstick, endocervical gram stain, and culture. Sex Transm Dis (1992) 0.94
Social and behavioral correlates of pelvic inflammatory disease. Sex Transm Dis (1998) 0.93
Praziquantel for the treatment of Clonorchis/Opisthorchis infections: report of a double-blind, placebo-controlled trial. J Infect Dis (1985) 0.93
Disease prevalence among women attending a sexually transmitted disease clinic varies with reason for visit. Sex Transm Dis (1992) 0.92
Pelvic inflammatory disease and tubal infertility: the preventable conditions. Ann N Y Acad Sci (1994) 0.87
Detection of Cryptosporidium oocysts in sputum during screening for mycobacteria. J Clin Microbiol (1984) 0.87
Are emergency departments the next frontier for sexually transmitted disease screening? Sex Transm Dis (2001) 0.82
Routine voluntary HIV screening in STD clinic clients: characterization of infected clients. Sex Transm Dis (1991) 0.81
Janus considers the HIV pandemic--harnessing recent advances to enhance AIDS prevention. Am J Public Health (1997) 0.81
Sexually transmitted diseases in the AIDS era. Development of STD diagnostics for resource-limited settings is a global priority. Sex Transm Dis (1991) 0.80
Accelerated Campaign to Enhance STD Services (ACCESS) for youth: successes, challenges, and lessons learned. Sex Transm Dis (1999) 0.77
Pelvic inflammatory disease and infertility. Md Med J (1987) 0.76
Syphilis: a barometer of community health. Sex Transm Dis (2000) 0.75
Rhabdomyolysis and acute renal failure: a new presentation of acute brucellosis. J Infect Dis (1984) 0.75
The NIAID Study Group on Integrated Behavioral Research for Prevention and Control of Sexually Transmitted Diseases. Part III: Issues in evaluating behavioral interventions. Sex Transm Dis (1991) 0.75
Risk-based versus alternative algorithms for antibiotic prophylaxis among women seeking early suction abortion: a cost-effectiveness simulation. Sex Transm Dis (2001) 0.75
Sexually transmitted diseases in women. Approach to common syndromes in emergency medicine. Emerg Med Clin North Am (1985) 0.75
Expanded NIAID support of STD research: STD Cooperative Research Centers. Sex Transm Dis (1991) 0.75